GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive.

The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of type 1 diabetes, it said on ...

The Self protocol applies to use cases ranging from sybil-resistant token distributions to OFAC sanctions compliance and ...

Some brands of common household items — think protein powder, cinnamon and cassava — have concerning amounts of lead, recent ...

NSL Analytical Services, Inc., based in Cleveland, Ohio, has shared a case study by Dr Ross Cunningham, Director of Science ...